NO3119782T3 - - Google Patents
Info
- Publication number
- NO3119782T3 NO3119782T3 NO15710486A NO15710486A NO3119782T3 NO 3119782 T3 NO3119782 T3 NO 3119782T3 NO 15710486 A NO15710486 A NO 15710486A NO 15710486 A NO15710486 A NO 15710486A NO 3119782 T3 NO3119782 T3 NO 3119782T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14160344 | 2014-03-17 | ||
| PCT/EP2015/055494 WO2015140132A1 (en) | 2014-03-17 | 2015-03-17 | 2,7-diazaspiro[3.5]nonane compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO3119782T3 true NO3119782T3 (forum.php) | 2018-06-30 |
Family
ID=50287962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO15710486A NO3119782T3 (forum.php) | 2014-03-17 | 2015-03-17 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9617264B2 (forum.php) |
| EP (1) | EP3119782B1 (forum.php) |
| JP (2) | JP6574438B2 (forum.php) |
| CN (1) | CN106103439B (forum.php) |
| AU (1) | AU2015233642B2 (forum.php) |
| CA (1) | CA2941196C (forum.php) |
| DK (1) | DK3119782T3 (forum.php) |
| EA (1) | EA032470B1 (forum.php) |
| ES (1) | ES2666173T3 (forum.php) |
| HR (1) | HRP20180585T1 (forum.php) |
| HU (1) | HUE038764T2 (forum.php) |
| NO (1) | NO3119782T3 (forum.php) |
| PL (1) | PL3119782T3 (forum.php) |
| PT (1) | PT3119782T (forum.php) |
| RS (1) | RS57129B1 (forum.php) |
| SI (1) | SI3119782T1 (forum.php) |
| WO (1) | WO2015140132A1 (forum.php) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201416352D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
| GB201416351D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
| US11149022B2 (en) | 2017-10-17 | 2021-10-19 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor M4 |
| US11325896B2 (en) | 2017-12-20 | 2022-05-10 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor M4 |
| GB2634848B (en) * | 2021-01-29 | 2025-08-27 | Korea Res Inst Chemical Tech | Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
| AR062789A1 (es) * | 2006-09-15 | 2008-12-03 | Schering Corp | Derivados de azetidina y azetidona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del dolor y de trastornos del metabolismo de los lipidos. |
| MX2012010772A (es) | 2010-03-19 | 2012-11-06 | Pfizer | Derivados de 2,3-dihidro-1h-inden-1-il-2,7-diazaspiro[3,5]nonano y su uso como antagonistas o agonistas inversos del receptor de grelina. |
| JP6399660B2 (ja) * | 2012-04-10 | 2018-10-03 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | 癌治療用組成物および方法 |
| DK2861566T3 (en) * | 2012-06-13 | 2017-02-27 | Hoffmann La Roche | NEW DIAZASPIROCYCLOALKANES AND AZASPIROCYCLOALKANES |
-
2015
- 2015-03-17 NO NO15710486A patent/NO3119782T3/no unknown
- 2015-03-17 US US15/121,790 patent/US9617264B2/en not_active Expired - Fee Related
- 2015-03-17 JP JP2016557898A patent/JP6574438B2/ja not_active Expired - Fee Related
- 2015-03-17 SI SI201530219T patent/SI3119782T1/en unknown
- 2015-03-17 ES ES15710486.0T patent/ES2666173T3/es active Active
- 2015-03-17 PT PT157104860T patent/PT3119782T/pt unknown
- 2015-03-17 HR HRP20180585TT patent/HRP20180585T1/hr unknown
- 2015-03-17 EA EA201691539A patent/EA032470B1/ru not_active IP Right Cessation
- 2015-03-17 CN CN201580013644.7A patent/CN106103439B/zh not_active Expired - Fee Related
- 2015-03-17 HU HUE15710486A patent/HUE038764T2/hu unknown
- 2015-03-17 WO PCT/EP2015/055494 patent/WO2015140132A1/en active Application Filing
- 2015-03-17 EP EP15710486.0A patent/EP3119782B1/en active Active
- 2015-03-17 DK DK15710486.0T patent/DK3119782T3/en active
- 2015-03-17 CA CA2941196A patent/CA2941196C/en active Active
- 2015-03-17 PL PL15710486T patent/PL3119782T3/pl unknown
- 2015-03-17 AU AU2015233642A patent/AU2015233642B2/en not_active Ceased
- 2015-03-17 RS RS20180427A patent/RS57129B1/sr unknown
-
2017
- 2017-02-15 US US15/433,164 patent/US9750745B2/en active Active
-
2019
- 2019-05-20 JP JP2019094697A patent/JP2019147834A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017507986A (ja) | 2017-03-23 |
| US20170157137A1 (en) | 2017-06-08 |
| EA032470B1 (ru) | 2019-05-31 |
| US9750745B2 (en) | 2017-09-05 |
| HUE038764T2 (hu) | 2018-11-28 |
| HRP20180585T1 (hr) | 2018-07-13 |
| JP6574438B2 (ja) | 2019-09-11 |
| CA2941196C (en) | 2019-09-03 |
| CN106103439A (zh) | 2016-11-09 |
| EP3119782B1 (en) | 2018-01-31 |
| PL3119782T3 (pl) | 2018-07-31 |
| EP3119782A1 (en) | 2017-01-25 |
| RS57129B1 (sr) | 2018-07-31 |
| JP2019147834A (ja) | 2019-09-05 |
| ES2666173T3 (es) | 2018-05-03 |
| US9617264B2 (en) | 2017-04-11 |
| SI3119782T1 (en) | 2018-06-29 |
| CN106103439B (zh) | 2019-03-08 |
| AU2015233642A1 (en) | 2016-09-08 |
| WO2015140132A1 (en) | 2015-09-24 |
| AU2015233642B2 (en) | 2017-08-03 |
| CA2941196A1 (en) | 2015-09-24 |
| PT3119782T (pt) | 2018-04-17 |
| EA201691539A1 (ru) | 2017-01-30 |
| US20170015665A1 (en) | 2017-01-19 |
| DK3119782T3 (en) | 2018-03-12 |